About Antrad
Antrad is a company based in Stockholm (Sweden) founded in 2008. Antrad has raised $3.5 million across 2 funding rounds from investors including Sting. Antrad offers products and services including Qthaw UFT200. Antrad operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Antrad Medical Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.5 M (USD)
in 2 rounds
-
Latest Funding Round
$2.36 M (USD), Series A
Aug 13, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antrad
Antrad offers a comprehensive portfolio of products and services, including Qthaw UFT200.
Rapid blood plasma thawing using patented radio wave energy.
People of Antrad
Unlock access to complete
Unlock access to complete
Funding Insights of Antrad
Antrad has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.36 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Antrad
Antrad has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Sting.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sting is recognized as a leading startup accelerator in the Nordics.
|
Locked | Locked | Locked |
Investor details for Antrad
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Antrad
Investment portfolio details for Antrad
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Antrad
Detailed financials for Antrad
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Antrad Comparisons
Peer comparison for Antrad
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Antrad
Antrad operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Developer of the device for controlling bleeding
|
|
| Locked | Locked | Locked |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| Locked | Locked | Locked |
Innovative solutions for safer blood transfusions are developed.
|
|
| Locked | Locked | Locked |
Cytopheresis systems for inflammatory conditions
|
|
| Locked | Locked | Locked |
Devices to facilitate blood component and bone marrow transplant
|
Detailed competitors of Antrad
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Antrad
Complete news archive for Antrad
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antrad
Antrad was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Antrad is headquartered in Stockholm, Sweden.
Antrad is a funded company, having raised a total of $3.5M across 2 funding rounds to date.
Antrad was founded in 2008 in Stockholm, Sweden, and operates in the medical device sector focused on blood plasma processing. The UFT100 unit is utilized to thaw two bags of plasma in five minutes, with no warm water involved to prevent bacterial contamination. Two units can be stacked for four bags in the same timeframe, supporting efficient space use in healthcare settings.
Antrad's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
Antrad offers Qthaw UFT200.
Antrad has 1 investor. Key investors include Sting.